Long-term treatment of myasthenia gravis with alternate-day prednisone. Report on 15 patients.
D000109:Acetylcholine; D000110:Acetylcholinesterase / Q000627:therapeutic use; D000200:Action Potentials; D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D004351:Drug Resistance; D004576:Electromyography; D005260:Female; D006801:Humans; D007269:Injections, Intra-Arterial; D008297:Male; D008875:Middle Aged; D009132:Muscles / Q000503:physiopathology; D009157:Myasthenia Gravis / Q000188:drug therapy* / Q000503:physiopathology / Q000628:therapy; D011241:Prednisone / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D013934:Thymectomy; D013997:Time Factors
D000110:Acetylcholinesterase; D000109:Acetylcholine; D011241:Prednisone